Observational Study on GEP-and Pulm-NET Treated at FPG
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
About this trial
Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.
Eligibility criteria
Qualifiers
histological diagnosis of gastroenteropancreatic or pulmonary NET
age ≥ 18 years;
radiological evidence of resectable/locally advanced/metastatic disease;
signing of informed consent;
Disqualifiers
absence of clinical data that allow adequate definition of survival (primary endpoint of the study);
absence of histological diagnosis;
failure to sign the informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
650 Participants
are grouped into 2 trial groupsLocations
1Fondazione Policlinico Universitario Agostino Gemelli - IRCCS00168, Rome Italy
Sponsors and collaborators
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead sponsor
Source ClinicalTrials.gov